BackGeron Overview

Geron Current Cash

Track Geron's current cash ($71M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$70.78M
↓ 15.48% YoYΔ $-12.97M vs prior year quarter

Peer average

Loading

Geron Current Cash History

Loading

Geron vs. peers: Current Cash Comparison

Loading

Geron Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Geron (GERN) FAQ

Geron (GERN) currently reports a current cash of $71M as of March 2026. That compares with $84M in the prior-year period — down 15.5% year over year. Use the charts on this page to explore Geron's current cash history and peer comparisons.

Geron's current cash decreased from $84M to $71M — a 15.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Geron reported $71M in current cash as of March 2026. That compares with $84M in the prior-year period — down 15.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $71M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Geron, and consider following GERN for alerts when major investors trade the stock.

Geron is classified in the Healthcare sector. On current cash, it currently shows $71M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GERN with unrelated industries.